Late anthracycline cardiotoxicity in pediatric age;Valutazione della cardiotossicita tardiva da antracicline in eta pediatrica

Minerva Pediatrica

Volumn 50, Issue 4, 1998, Pages 111-119

  Butera, G ^a,b   Piciacchia, D ^a   Chessa, M ^a   Condoluci, C ^a   Tornesello, A ^a   Delogu, A B ^a   Mastrangelo, S ^a   Cipriani, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Servizio di Cardiologia Pediatrica   (Italy)

Author keywords

Anthracyclines adverse effects cardiotoxicity; Child; Diastole; Systole

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DAUNORUBICIN; DOXORUBICIN; ANTHRACYCLINE;

ADOLESCENT; AGE; ARTICLE; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL ARTICLE; DOPPLER FLOWMETRY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; M MODE ECHOCARDIOGRAPHY; MALE; SCHOOL CHILD; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DIASTOLE; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART; INFANT; NEOPLASM; PRESCHOOL CHILD; STATISTICAL ANALYSIS; SYSTOLE; TIME;

AGE FACTORS; ANTHRACYCLINES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; INFANT; MALE; NEOPLASMS; SYSTOLE; TIME FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0031788898     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bonadonna G Antracicline. In: Manuale di Oncologia Medica Milano Ed Masson, 1991:476-83.
2. Lefrak EA, Pitha J, Resenheim. Gottlieb JA A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973,32.302-14
3. Von Hoff DD, Layard MW, Basa P, Davis HL, Von Hoff AL, Rozencweig M Risk factors for doxorubicin induced congestive heart failure. Ann Intern Med 1979,91: 701-7.
4. Bristow MR, Mason W, Billingham ME, Daniels JR. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy Am Heart J 1981;192:709-18
5. Ace A. The cardiotoxicity of chemotherapeutic drugs In: Perry MC, editor. The Chemotherapy Source Book. Baltimora Ed Williams & Wilkins, 1989.582-97
6. Fu XL, Jiang GL, Wang Lj, Zhao FM, Liu JF A new insight into adrvamicin induced cardiotoxicity Int J Cardiol 1990;29:15-9.
7. Cummings J, Anderson L, Wilcott N, Smith JF, The molecular pharmacology of doxorubicin in vivo. Eur J Cancer 1991,27:532-5.
8. Olson RD, Mushlin PS, Doxorubicin cardiotoxicity analysis of prevailing hypetheses. FASEB J 1990,4.3076-86.
9. Jensen RA. Doxorubicin cardiotoxicity: contractility changes after long term treatment in the rat. J Pharmacol Exp Ther 1986;236 197-203
10. Kim DH Doxorubicin induced calcium release from sarcoplasmic reticulum vescicles J Mol Cell Cardiol 1989;21 433-6.
11. Doroshow JH. Effect of antracvcline antibiotics on oxygen radical formation in rat heart Cancer Res 1983; 43:460-72
12. Lee V, Randhawa AK, Singal PK Adryamicin induced myocardial dysfunction in vitro is mediated by free radicals Am J Physiol 1991;261.H989-H995
13. Doroshow JH Doxorubicin induced cardiac toxicity. N Engl J Med 1991:324.843-5.
14. Makinen L, Makipernoa A, Rautonen J, Heino M, Pyrhonen S, Lantinen LA. et al. Long cardiac sequelae after treatment of malignant tumors with radiotherapy or citostatics in childhood Cancer 1990,65.1913-7
15. Gottlieb LS, Edmiston WE, Haywood LJ. Late, late doxorubicin cardiotoxicity. Chest 1980;78:880-2.
16. Steinherz LJ, Steinherz P Cardiac failure more then 6 years post anthraciclynes (abstract). Am J Cardiol 1988;505:22
17. Byrd R. Late effects of treatment of cancer in children Pediatr Clin North Am 1985,32(3):835-7
18. Goorin AM, Chauvenet AR, Peres Atayde AR, Cruz J, McKone R, Lipshultz SE Initial congestive heart failure 6 to 10 Years after Doxorubicin chemotherapy for childhood cancer. Clin Lab Obs 1989;116(1):144-7
19. Koh E, Imashuku S, Kiyosawa a N, Sawada T Anthraciclyne-induced congestive heart failure in two pediatric leukemia cases and long-term follow-up. Pediatr Hematol Oncol 1988,5 245-51
20. Freter CE, Lee TC Billingham ME, Chak L, Bristow MR. Doxorubicin cardiotoxicity manifestating seven years after treatment Am J Med 1980;80:483-5.
21. Lipshultz SE, Colan SD, Sanders SP et al Late myocardial growth impairment in children trated with Adriamycin (abstract). Am J Cardiol 1991;64(3).416.
22. Steinherz LJ, Murphy ML, Steinherz P et al. Long term cardiac follow-up 4-13 years after Anthracycline therapy In: Doyle E et al., editors. Pediatric Cardiology New York: Springer Verlag, 1986;1058-61.
23. Yeung ST, Yoong C, Spink J, Galbraith A, Smith PJ Functional myocardial impairment in children treated with antracyclines for cancer. Lancet 1991;337 816-8.
24. Koch H. Long term control of anthracycline-induced cardiomyopathy in children and adlolescents. Klin Pediatr 1991;203:262-7.
25. Meister AL, Meadows AT. Effetti collaterali tardivi della terapia oncologica infantile. Curr Probl Ped. Saint-Louis: Mosby-Year Book. 1993,162-9
26. Lipshultz SE. Cardiovascular abnormalities in long-term survivors of childhood malignancy (Editorial). J Clin Oncol 1993;11(7).1199-203.
27. Steinherz LJ, Steinherz P, Tan CT, Heller G, Murphy ML Cardiac toxicity 4 to 10 years after completing anthracycline therapy. JAMA 1991,266(12).1672-7
28. Lipshultz SE, Colan SD, Gilber RD, Perez Atayae AR, Sallan SE, Sanders SP. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 1991,324(12) 808-15.
29. Hausdorf G, Morf G, Beron G, Ertmann R, Winkler K, Landbeck G, Keck EW. Long-term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling. Br Heart J 1988;60:309-15
30. Lang D, Hilger F, Bingwanger J, Andelfinger G, Hartmann W Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. Eur J Pediatr 1995;154: 340-5.
31. Lipshultz SE, Sollan SE Cardiovascular abnormalities in long term survivors of childhood malignancy. J Clin Oncol 1993;11 1199-203
32. Sorensen K, Levitt G, Sebag-Montefiore L, Bull C, Sullivan I. Cardiac function in Wilms' tumor survivors. J Clin Oncol 1995;13:1546-56.
33. Bu'Lock FA, Mott MG, Oakhill A, Mortin RP Left ventricular diastolic function after anthracycline chemiotherapy in childhood, relation with systolic function, symptoms and pathophysiology. Br Heart J 1995,73:340-50.
34. Shan K, Lincoff AM, Young JB. Anthracycline-induced cardiotoxicity. Ann Intern Med 1996;125:47-58
35. Zarich SW, Arbuckle BE, Cohen LR, Roberts M, Nesto RW Diastolic abnormalities in young asvmptomatic diabetic patients assessed by pulsed Doppler echocardiography. JACC 1988,12(1):114-20.
36. Nishimura A, Abel MD, Hatle LK, Tajik J Assessment of diastolic function of the heart: background and current applications of Doppler echocardiography Part II. Clinical studies. Mayo Clin Proc 1989;64:181-204
37. Spirito P, Maron BJ Doppler echocardiography for assessing left ventricular diastolic function. Ann Intern Med 1988;109:122-6
38. Sorensen K, Levitt G, Bull C et al Antrhacycline dose in childhood acute lymphoblastic leukemia, issues of early survival versus late cardiotoxicity J Clin Oncol 1997;15:61-8
39. Zak R. Development of proliferative capacity of cardiac muscle cells. Cir Res 1980;35(Suppl II):II-17-II-26
40. Clubb FJ, Bishop JP. Formation of binucleated myocardial cells in the neonatal rat: an index for growth hypertrophy. Lab invest 1984;50:571-7
41. a parte. IV(3):417-24
42. a parte. IV(3):417-24
43. Moretensen SA, Olsen HS, Baandrup U. Chronic anthraciclyne cardiotoxicity: haemodinamic and histopatological manifestations suggesting a restrictive endomyocardial disease. Br Heart J 1986;55:274-82
44. Bleyer WA The impact of childhood cancer on the United States and the World. CA Cancer J Clin 1990,40:355-67
45. Steinherz LJ, Graham T, Hurwita R, Sondeheimer HM, Scwartz RG, Shaffer EM et al Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Children Cancer Study Group. Pediatrics 1992;89.942-9.
46. Lipshultz SE, Sanders SP, Goorin AP, Krischer JP, Sallan SE, Colan SD Monitoring for anthracycline cardiotoxicity. Pediatrics 1994;93.433-7.